Home Cart 0 Sign in  
X

[ CAS No. 214701-49-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 214701-49-2
Chemical Structure| 214701-49-2
Chemical Structure| 214701-49-2
Structure of 214701-49-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 214701-49-2 ]

Related Doc. of [ 214701-49-2 ]

Alternatived Products of [ 214701-49-2 ]

Product Details of [ 214701-49-2 ]

CAS No. :214701-49-2 MDL No. :MFCD04974523
Formula : C7H6BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :IDZRAUUUHXQGKC-UHFFFAOYSA-N
M.W : 200.03 Pubchem ID :23145345
Synonyms :

Calculated chemistry of [ 214701-49-2 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 42.13
TPSA : 29.96 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.41 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.95
Log Po/w (XLOGP3) : 1.56
Log Po/w (WLOGP) : 2.05
Log Po/w (MLOGP) : 0.89
Log Po/w (SILICOS-IT) : 2.33
Consensus Log Po/w : 1.76

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.44
Solubility : 0.725 mg/ml ; 0.00362 mol/l
Class : Soluble
Log S (Ali) : -1.8
Solubility : 3.18 mg/ml ; 0.0159 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.22
Solubility : 0.121 mg/ml ; 0.000605 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.42

Safety of [ 214701-49-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 214701-49-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 214701-49-2 ]
  • Downstream synthetic route of [ 214701-49-2 ]

[ 214701-49-2 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 676-58-4 ]
  • [ 214701-49-2 ]
  • [ 290307-40-3 ]
YieldReaction ConditionsOperation in experiment
100% at 0 - 20℃; for 1 h; Step 3.
2-(5-bromopyridin-2-yl)propan-2-ol
Methylmagnesium chloride 3.0M in THF (0.3 mL) was added dropwise to a mixture of 1-(5-bromopyridin-2-yl)ethanone (100 mg, 0.5 mmol) in tetrahydrofuran (10 mL) at 0° C.
After stirring for 1 h at room temperature, the reaction was quenched with 1N NH4Cl and was extracted with EtOAc.
The combined organic layer was washed with brine and dried over MgSO4, concentrated to give crude 2-(5-bromopyridin-2-yl)propan-2-ol (0.1 g, 100percent). LCMS calculated for C8H11BrNO (M+H)+: m/z=215.9, 217.9. found: 215.8, 217.8.
86% at 0 - 20℃; for 12 h; To a stirred solution of 1-(5-bromopyridin-2-yl)ethan-1-one (1 , 6.2 g, 30.99 mmol) in tetrahydrofuran (100 mL), was added methyl magnesium chloride solution (18.6 mL, 55.78 mmol, 3.0 M in tetrahydrofuran) at 0 C and the reaction mixture was then stirred at room temperature for 12 h. The reaction mixture was quenched with saturated ammonium chloride solution (50 mL) and extracted with ethyl acetate (3 x 100 mL). The combined organic layer was dried over anhydrous sodium sulphate, filtered and concentrated. The crude product was purified by silica gel column chromatography using 10percent ethyl acetate in hexane to afford the title compound 2-(5-bromopyridin-2-yl)propan-2-ol (2, 5.8 g, 86percent yield) as a yellow oil. Calculated (M+H): 216.0; Found (M+H): 216.1
Reference: [1] Patent: US2014/249132, 2014, A1, . Location in patent: Paragraph 0513
[2] Patent: WO2018/119374, 2018, A1, . Location in patent: Paragraph 00371
  • 2
  • [ 75-16-1 ]
  • [ 214701-49-2 ]
  • [ 290307-40-3 ]
YieldReaction ConditionsOperation in experiment
53% at -78 - 20℃; To a solution of 1-(5-bromopyridine-2-yl)ethanone (2.9 g, 14.5 mmol) inanhydrous THF (87 mL) at -78 °C was added methylmagnesium bromide (38.66 mL,116.0 mmol) (3M in diethyl ether) dropwise. The resulted mixture was stirred at room temperature for overnight. Saturated ammonium chloride solution was added and the mixture stirred for 30 mm, then extracted with ethyl acetate. The organic layer was dried over sodium sulfate, concentrated and purified by column chromatography (60-120 silicagel, 2-3percent EtOAc/hexane) to gave the product of Step 2 (1.66 g, 53percent yield) as a pale yellow liquid. LCMS retention time: 1.40 mm (Method 8).
42% at -15 - 25℃; for 5 h; Inert atmosphere 2-(5-Bromopyridin-2-yl)propan-2-ol (B25.1) (0431) To a mixture of 1-(5-bromopyridin-2-yl)ethanone (400 mg, 2 mmol) in 8 mL THF was added 6 mL CH3MgBr (1 mol/L) at −15° C. under N2 atmosphere. The mixture was stirred for 5 h at 25° C., quenched with sat. NH4CI (30 mL) and stirred for 1 h, extracted with ethyl acetate (50 mL×2). The combined organic layers were washed with 50 mL water and 50 mL brine, dried over Na2SO4, concentrated. The residue was purified on silica gel (PE/EA=10:1) to give title compound (180 mg, 42percent) as a colorless oil. 1H-NMR (400 MHz, CDCl3) δ ppm 1.54 (s, 6H), 7.31 (dd, 1H), 7.82 (dd, 1H), 8.58 (d, 1H).
42% at -15 - 25℃; for 5 h; Inert atmosphere To a mixture of 1 -(5- bromopyridin-2-yl)ethanone (400 mg, 2 mmol) in 8 mL THF was added 6 mL CH3MgBr (1 mol/L) at -15 °C under N2 atmosphere. The mixture was stirred for 5 h at 25 °C, quenched with sat. NH4CI (30 mL) and stirred for 1 h, extracted with ethyl actetate (50 mL x 2). The combined organic layers were washed with 50 mL water and 50 mL brine,dried over Na2SO4, concentrated. The residue was purified on silica gel (PE/EA1O:1)to give title compound (180 mg, 42percent) as a colorless oil. 1H-NMR (400 MHz, CDCI3) O ppm 1.54 (5, 6H), 7.31 (dd, 1H), 7.82 (dd, 1H), 8.58 (d, 1H).
Reference: [1] Patent: WO2015/27021, 2015, A1, . Location in patent: Page/Page column 79
[2] Patent: US2016/176882, 2016, A1, . Location in patent: Paragraph 0430; 0431
[3] Patent: WO2017/221100, 2017, A1, . Location in patent: Paragraph 00219
  • 3
  • [ 624-28-2 ]
  • [ 127-19-5 ]
  • [ 214701-49-2 ]
YieldReaction ConditionsOperation in experiment
100% With n-butyllithium In hexane; toluene at -40 - 20℃; for 2 h; Inert atmosphere 2,5-dibromo-pyridine (I-1-1) 8g the (33.7mmol) and toluene 337mL was stirred at -40 under a nitrogen atmosphere. After stirring for 40 minutes was added n- butyl lithium 1.6M in hexane 21.4mL a (1.02eq) in which, in addition N, N-dimethylacetamide (DMAc) 9.38mL (3.0eq), stirred It was slowly heated to 20 while. Thereafter, saturated aqueous ammonium chloride solution was added to quench the reaction, and extraction and liquid separation. The extract was purified by silica gel column chromatography,2-acetyl-5-bromopyridine to give (compound the I-1-2) of a white solid 6.74 g (100percent yield).
65%
Stage #1: With n-butyllithium In hexane; toluene at -50℃; for 0.75 h;
Stage #2: at -50 - 20℃; for 1 h;
To a solution of 2,5-dibromopyridine (5 g, 22.026 mmol) in anhydrous toluene (200 mL) at -50 °C was added n-butyllithium (13.75 mL, 22.026 mmol) (1.6M in hexane) dropwise. The resulted mixture was stirred at -50 °C temperature for 45 mi N,Ndimethylacetamide (3.61 mL, 37.44 mmol) was added dropwise at the same temperatureand then allowed to reach room temperature slowly. The reaction mixture was stirred at room temperature for 1 h and quenched with saturated ammonium chloride solution, then extracted with EtOAc. The organic layer was dried over sodium sulfate, concentrated and purified by column chromatography (60-120 silica gel, 1percent EtOAc/hexane) to provide the product of Step 1 (2.9 g, 65percent yield) as a white solid. LCMS retention time: 1.46 mm(Method 7).
Reference: [1] Patent: JP2016/56276, 2016, A, . Location in patent: Paragraph 0111; 0112
[2] Tetrahedron, 2008, vol. 64, # 17, p. 3794 - 3801
[3] Dalton Transactions, 2011, vol. 40, # 29, p. 7534 - 7540
[4] Journal of the American Chemical Society, 2016, vol. 138, # 38, p. 12643 - 12647
[5] Patent: WO2015/27021, 2015, A1, . Location in patent: Page/Page column 78
[6] Patent: WO2012/21467, 2012, A1, . Location in patent: Page/Page column 32
  • 4
  • [ 75-16-1 ]
  • [ 97483-77-7 ]
  • [ 214701-49-2 ]
YieldReaction ConditionsOperation in experiment
65%
Stage #1: at -20 - -10℃; for 3 h;
Stage #2: With hydrogenchloride; water In tetrahydrofuran at -40 - -35℃; for 0.166667 h;
Intermediate 10: 1-(5-Bromopyridin-2-yl)ethanone; see W098/46605; 5-Bromo-2-cyanopyridine (Markevitch, David Y.; Rapta, Miroslav; Hecker, Scott J. ; Renau, Thomas E. ; Synth. Commun.; 33; 19; 2003; 3285 - 3290) (8 g, 43.7 mmol) was dissolved in dry THF (200 mL) and cooled to - 20°C. Methylmagnesium bromide (43.7 mL, 3M) was added drop wise and the temperature was held between -20°C and -10°C for 3 hours. The reaction mixture was cooled to -40°C and conc. HCI (4.5 mL) in water (15 mL) was added dropwise. It was stirred for 10 minutes at -35°C and then poured into a beaker with potassium phosphate buffer (300 mL, 1M, pH 7), under stirring. Ethyl acetate (300 mL) was added and the organic phase was dried over sodium sulfate. Upon concentration at room temperature under reduced pressure to - 50 mL the product crystallized, 2.4 g, mp 112°C. The mother liquor was further concentrated and chromatographed on silica gel with dichloromethane/ ethylacetate (100:1) to give another 3.25 g product (65percent combined yield). 1H-NMR (DMSO-d6) No.: 2.60 (s, 3H) ; 7.88 (dd, 1H); 8.25 (dd, 1H); 8.86 (d, 1H).
65%
Stage #1: at -20 - -10℃; for 3 h;
Stage #2: With hydrogenchloride; water In tetrahydrofuran at -40 - -35℃; for 0.166667 h;
Stage #3: potassium phosphate buffer
Intermediate 10: 1-(5-Bromopyridin-2-yl)ethanone; See W098/46605; 5-Bromo-2-cyanopyridine (Markevitch, David Y. ; Rapta, Miroslav; Hecker, Scott J. ; Renau, Thomas E. ; Synth. Commun.; 33; 19; 2003; 3285 - 3290) (8 g, 43.7 mmol) was dissolved in dry THF (200 mL) and cooled to - 20°C. Methylmagnesium bromide (43.7 mL, 3M) was added drop wise and the temperature was held between -20°C and -10°C for 3 hours. The reaction mixture was cooled to -40°C and concentrated HCl (4.5 mL) in water (15 mL) was added dropwise. It was stirred for 10 minutes at -35°C and then poured into a beaker with potassium phosphate buffer (300 mL, 1M, pH 7), under stirring. Ethyl acetate (300 mL) was added and the organic phase was dried over sodium sulfate. Upon concentration at room temperature under reduced pressure to - 50 mL the product crystallized, 2.4 g, mp 112°C. The mother liquor was further concentrated and chromatographed on silica gel with dichloromethane/ ethylacetate (100:1) to give another 3.25 g product (65percent combined yield). (at)H-NMR (DMSO-d(at)) No.: 2.60 (s, 3H) ; 7.88 (dd, 1H) ; 8.25 (dd, 1H) ; 8.86 (d, 1H).
30%
Stage #1: at -20℃; for 3 h;
Stage #2: With hydrogenchloride; water In tetrahydrofuran; diethyl ether at -40℃;
5-Bromopicolinonitrile (5.4 g, 29.7 mmol) was dissolved in anhydrous THF (120 mL) and cooled to -200C. MeMgBr (35 mL, IM in Et2O) was added dropwise, and the reaction mixture was stirred at -200C for 3 h. The reaction mixture was cooled to -40 0C, and neutralized with cone. HCl. The solvent was removed under reduced pressure. The residue was dissolved in EtOAc and washed with water. The aqueous layer was extracted with EtOAc. The combined organic phase was dried (Na2SO4) and evaporated under vacuum. The crude product was purified by column chromatography on silica gel (EtOAc - hexanes) to give l-(5-bromopyridin-2-yl)ethanone (1.9 g, 30percent yield).
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 20, p. 4868 - 4881
[2] Patent: WO2005/116022, 2005, A1, . Location in patent: Page/Page column 44
[3] Patent: WO2005/116023, 2005, A1, . Location in patent: Page/Page column 44-45
[4] Organic and Biomolecular Chemistry, 2015, vol. 13, # 36, p. 9418 - 9426
[5] Patent: WO2008/108988, 2008, A1, . Location in patent: Page/Page column 67
[6] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 22, p. 5909 - 5915
  • 5
  • [ 1211592-38-9 ]
  • [ 676-58-4 ]
  • [ 214701-49-2 ]
YieldReaction ConditionsOperation in experiment
90% at 0 - 20℃; for 1 h; Step 2.
1-(5-bromopyridin-2-yl)ethanone
Methylmagnesium chloride 3.0M in THF (0.5 mL) was added dropwise to a mixture of 5-bromo-N-methoxy-N-methylpyridine-2-carboxamide (200 mg, 0.8 mmol) in tetrahydrofuran (10 mL) at 0° C.
After stirring for 1 hr at room temperature, the reaction was quenched with 1N NH4Cl and was extracted with EtOAc.
The combined organic layer was washed with brine and dried over MgSO4, concentrated to give the crude product 1-(5-bromopyridin-2-yl)ethanone (0.15 g, 90percent). LCMS calculated for C7H7BrNO (M+H)+: m/z=199.9, 201.9. found: 199.9, 201.9.
Reference: [1] Patent: US2014/249132, 2014, A1, . Location in patent: Paragraph 0512
  • 6
  • [ 676-58-4 ]
  • [ 97483-77-7 ]
  • [ 214701-49-2 ]
Reference: [1] Patent: WO2008/91681, 2008, A2, . Location in patent: Page/Page column 239
[2] Patent: US2010/16298, 2010, A1, . Location in patent: Page/Page column 202
  • 7
  • [ 845305-87-5 ]
  • [ 917-54-4 ]
  • [ 214701-49-2 ]
Reference: [1] Patent: WO2013/91096, 2013, A1, . Location in patent: Page/Page column 78-79
  • 8
  • [ 111770-80-0 ]
  • [ 214701-49-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2005, vol. 13, # 11, p. 3705 - 3720
  • 9
  • [ 624-28-2 ]
  • [ 214701-49-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 22, p. 5909 - 5915
  • 10
  • [ 30766-11-1 ]
  • [ 214701-49-2 ]
Reference: [1] Patent: WO2013/91096, 2013, A1,
[2] Patent: US2014/249132, 2014, A1,
  • 11
  • [ 223463-13-6 ]
  • [ 214701-49-2 ]
Reference: [1] Patent: WO2013/144224, 2013, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 214701-49-2 ]

Bromides

Chemical Structure| 31181-90-5

[ 31181-90-5 ]

5-Bromopicolinaldehyde

Similarity: 0.88

Chemical Structure| 1060805-69-7

[ 1060805-69-7 ]

1-(4-Bromopyridin-2-yl)ethanone

Similarity: 0.86

Chemical Structure| 17570-98-8

[ 17570-98-8 ]

2-(Bromoacetyl)pyridine hydrobromide

Similarity: 0.84

Chemical Structure| 38749-90-5

[ 38749-90-5 ]

5-Bromo-2-ethylpyridine

Similarity: 0.83

Chemical Structure| 886364-94-9

[ 886364-94-9 ]

5-Bromo-4-methylpicolinaldehyde

Similarity: 0.81

Ketones

Chemical Structure| 1060805-69-7

[ 1060805-69-7 ]

1-(4-Bromopyridin-2-yl)ethanone

Similarity: 0.86

Chemical Structure| 17570-98-8

[ 17570-98-8 ]

2-(Bromoacetyl)pyridine hydrobromide

Similarity: 0.84

Chemical Structure| 5308-63-4

[ 5308-63-4 ]

1-(5-Methylpyridin-2-yl)ethanone

Similarity: 0.76

Chemical Structure| 59576-26-0

[ 59576-26-0 ]

1-(4-Methylpyridin-2-yl)ethanone

Similarity: 0.76

Chemical Structure| 22971-32-0

[ 22971-32-0 ]

2-Butyrylpyridine

Similarity: 0.76

Related Parent Nucleus of
[ 214701-49-2 ]

Pyridines

Chemical Structure| 31181-90-5

[ 31181-90-5 ]

5-Bromopicolinaldehyde

Similarity: 0.88

Chemical Structure| 1060805-69-7

[ 1060805-69-7 ]

1-(4-Bromopyridin-2-yl)ethanone

Similarity: 0.86

Chemical Structure| 17570-98-8

[ 17570-98-8 ]

2-(Bromoacetyl)pyridine hydrobromide

Similarity: 0.84

Chemical Structure| 38749-90-5

[ 38749-90-5 ]

5-Bromo-2-ethylpyridine

Similarity: 0.83

Chemical Structure| 886364-94-9

[ 886364-94-9 ]

5-Bromo-4-methylpicolinaldehyde

Similarity: 0.81